(21)Commission Implementing Regulation (EU) 2023/689 of 20 March 2023note extended the period of approval of mepanipyrim until 15 March 2025 in order to allow the renewal process to be completed before the expiry of the approval period of that substance. However, given that a decision on the non-renewal of the approval is taken ahead of the expiry of that extended approval period, this Regulation should apply earlier than that date.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.